isoxazoles has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aidinis, V; Budd, DC; Kaffe, E; Müller, S; Ninou, I; Stevenson, CS; Ullmer, C | 1 |
| Batteux, F; Bordenave, J; Cumont, A; Dinh-Xuan, AT; Guignabert, C; Guilbert, T; Günther, S; Hua-Huy, T; Humbert, M; Jalce, G; Nicco, C; Quatremarre, T; Savale, L; Thuillet, R; Tu, L | 1 |
2 other study(ies) available for isoxazoles and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
Topics: Animals; Benzoxazoles; Biphenyl Compounds; Bleomycin; Idiopathic Pulmonary Fibrosis; Isoxazoles; Kaplan-Meier Estimate; Lung; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Random Allocation | 2018 |
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
Topics: Animals; Antigens, Differentiation, B-Lymphocyte; Bleomycin; Disease Models, Animal; Female; Histocompatibility Antigens Class II; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Inflammation; Intramolecular Oxidoreductases; Isoxazoles; Lung; Macrophage Migration-Inhibitory Factors; Male; Mice; Receptors, CXCR4; Vascular Remodeling | 2018 |